AUDIO from Medialink and Duramed Pharmaceuticals: Option to Alleviate Menopausal Symptoms

NEW YORK, Sept. 3 Approximately 5,700 women entermenopause every day. Many women are seeking relief for the symptomsassociated with menopause. Unfortunately, not all available treatment optionsare FDA-approved for their safety and efficacy. Here's more information on anavailable option that is well tested and FDA-approved.

Listen to this report from Duramed Pharmaceuticals at:http://media.medialink.com/WebNR.aspx?story=35514

Registered journalists can access video, audio, text, graphics and photosfor free and unrestricted use at http://www.mediaseed.tv.

09NY08-0085

SOURCE Medialink and Duramed Pharmaceuticals

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...